A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 15, 2015

Primary Completion Date

October 20, 2016

Study Completion Date

October 20, 2016

Conditions
Pelvic Adhesions
Interventions
DRUG

L-Alanyl/L-Glutamine

Sterile solution of L-Alanyl-L-Glutamine, 400mg/mL in water for injection. It is dosed at 1g/kg of body weight and is instilled into the peritoneum at the time of surgery. The active ingredient, glutamine, is a conditionally essential amino acid component of nutritional supplements.

DRUG

Physiologic saline

Placebo

Trial Locations (1)

Unknown

8Surgery and Endoscopy Department of Kharkiv Medical Academy of Postgraduate Education Kharkiv City Clinical Multi-field Hospital, Kharkiv

All Listed Sponsors
lead

Temple Therapeutics BV

INDUSTRY

NCT01701193 - A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions | Biotech Hunter | Biotech Hunter